Management ChangeAug 13, 2026, 07:18 AM
Cellebrite Appoints Shiven Ramji CEO; Q2 Results Mixed, FY26 Outlook Revised
AI Summary
Cellebrite DI Ltd. announced Shiven Ramji as its new CEO, succeeding Thomas E. Hogan, as part of a planned transition. The company reported mixed second-quarter 2026 results, with total ARR up 21% to $507.8 million and revenue up 16% to $131.1 million. However, ARR was below expectations, leading to a lowered full-year 2026 ARR and revenue outlook, while the Adjusted EBITDA target was raised due to operating discipline.
Key Highlights
- Shiven Ramji appointed CEO, succeeding Thomas E. Hogan, effective immediately.
- Q2 2026 Total ARR increased 21% year-over-year to $507.8 million.
- Q2 2026 Revenue grew 16% year-over-year to $131.1 million.
- Q2 2026 Non-GAAP Diluted EPS was $0.11.
- Q2 2026 Adjusted EBITDA reached $31.8 million (24.2% margin).
- Full-year 2026 ARR outlook lowered to $550M-$560M.
- Full-year 2026 Revenue outlook lowered to $555M-$561M.
- Full-year 2026 Adjusted EBITDA target raised to $153M-$159M.
Price Impact
More from CLBT